Characteristics of patients in the AIM and ATTAIN studies.
| Study Group | Age*, mean (SD) | Patient Characteristic | RA Duration*, mean (SD) | |
|---|---|---|---|---|
| Sex, % female | Race, % Caucasian | |||
| ATTAIN | ||||
| Abatacept, n = 258 | 53 (12.4) | 77 | 96 | 12 (8.5) |
| Control, n = 133 | 53 (11.3) | 80 | 93 | 11 (8.9) |
| Both Groups, n = 391 | 53 (12.1) | 78 | 95 | 12 (8.6) |
| AIM | ||||
| Abatacept, n = 433 | 52 (12.9) | 78 | 88 | 9 (7.3) |
| Control, n = 219 | 50 (12.4) | 82 | 88 | 9 (7.1) |
| Both Groups, n = 652 | 51 (12.7) | 79 | 88 | 9 (7.2) |
| Both Studies | ||||
| Abatacept, n = 691 | 52 (12.8) | 78 | 91 | 10 (7.9) |
| Control, n = 352 | 51 (12.0) | 81 | 90 | 10 (7.9) |
| Both Groups, n = 1043 | 52 (12.5) | 79 | 91 | 10 (7.9) |
↵* in years